RELiZORB works to hydrolyze available fats prior to ingestion of enteral formula. Here’s how.

How RELiZORB Works to Hydrolyze Available Fats Prior to Ingestion

  1. Inside the RELiZORB cartridge is the digestive enzyme lipase, which is covalently bound and immobilized to small white beads. This proprietary lipase-bead complex is called iLipase™.
  2. When enteral formula flows through RELiZORB, the lipase bound to the beads hydrolyzes fats from their triglyceride form, including long-chain triglycerides, one of the most difficult to hydrolyze, to allow for the delivery of absorbable fatty acids and monoglycerides, including the omega-3 fats DHA (docosahexaenoic acid) and EPA (eicosapentaenoic acid).
  3. Fatty acids such as the omega-3 fats DHA and EPA then become available to be absorbed by the patient.

Watch a Video on How RELiZORB Works

Relizorb 2017 (1)


This information is intended for
US healthcare professionals


You are now leaving the RELiZORB
product website to view the
Alcresta Therapeutics corporate website.